Therapy Areas
15 January 2026 - French healthcare company Sanofi S.A. (Euronext Paris:SAN) (Nasdaq:SNY) announced on Thursday that China's National Medical Products Administration has approved two Sanofi-licensed medicines: Myqorzo (aficamten) for the treatme...
15 January 2026 - US-based AVEO Oncology, an LG Chem (KRX:051910) company, announced on Wednesday that the first patient has been successfully dosed in a Phase 1b/2 clinical trial evaluating ficlatuzumab in combination with azacitidine and venetoclax...
15 January 2026 - Precision medicine reporting solutions company GenomOncology (GO) announced on Wednesday that it has formed a strategic partnership with Oregon Health & Science University's (OHSU) Knight Diagnostics Lab (KDL) to enhance cl...
14 January 2026 - Biotechnology company Cereno Scientific (Nasdaq First North: CRNO B) on Wednesday reported publication of the first peer-reviewed manuscript on its HDAC inhibitor CS014 in the Journal of Thrombosis and Haemostasis, disclosing molecu...
14 January 2026 - STEERLife, the life sciences division of India-based STEER World, and Bionpharma Inc, a US-based pharmaceutical company, announced on Tuesday that Bionpharma has received Abbreviated New Drug Application (ANDA) approval from the US ...
14 January 2026 - Biotechnology company Rakuten Medical Inc announced on Wednesday that it has signed a biopharmaceutical contract manufacturing agreement with LOTTE Biologics, a South Korea-based company that operates integrated biologics facilities...
13 January 2026 - Kestra Medical Technologies, Ltd. (NASDAQ: KMTS), a US-based wearable medical device and digital healthcare company, announced on Tuesday that it has entered a strategic collaboration with Israeli-American medical technology company...